Echo Therapeutics, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011
Licensing revenue
Other revenue
Licensing revenues
Operating expenses:
Research and development
Selling, general and administrative
Impairment charge
Loss on disposal of property and equipment
Depreciation and amortization
Total operating expenses
Loss from operations
Other income (expense):
Interest income
Financing loss
Amortization of deferred financing costs
Interest expense
Debt financing costs
Loss on extinguishment of debt/payables
Gain (loss) on disposals of assets
Other income
Gain on revaluation of derivative warrant liability
Other income (expense), net
Net loss before taxes
State income taxes
Net loss
Deemed dividend on beneficial conversion feature convertible preferred stock
Deemed dividend on repricing of warrants
Accretion of dividends on Series B Convertible Perpetual Redeemable Preferred Stock
Net loss applicable to common shareholders
Net loss per common share, basic and diluted
Basic and diluted weighted average common shares outstanding

Comments